Gene · 6530
Papers3,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,539
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional characterization of the biogenic amine transporters on human macrophages. | JCI Insight | 2022 | 35015729 | PubTator, text mining | PubMed |
| F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation. | J Nucl Cardiol | 2022 | 34993893 | PubTator, text mining | PubMed |
| Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging. | Nanotheranostics | 2022 | 34976584 | PubTator, text mining | PubMed |
| Mechanisms of ketamine and its metabolites as antidepressants. | Biochem Pharmacol | 2022 | 34968492 | PubTator, text mining | PubMed |
| Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder. | Int J Neuropsychopharmacol | 2022 | 34958348 | PubTator, text mining | PubMed |
| CHRNA2: a new paradigm in beige thermoregulation and metabolism. | Trends Cell Biol | 2022 | 34952750 | PubTator, text mining | PubMed |
| A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. | Brain | 2022 | 34919634 | PubTator, text mining | PubMed |
| Whole-Body Imaging to Assess Cell-Based Immunotherapy: Preclinical Studies with an Update on Clinical Translation. | Mol Imaging Biol | 2022 | 34816284 | PubTator, text mining | PubMed |
| Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease. | Behav Brain Res | 2022 | 34755639 | PubTator, text mining | PubMed |
| Design Strategies, Chemistry and Therapeutic Insights of Multi-target Directed Ligands as Antidepressant Agents. | Curr Neuropharmacol | 2022 | 34727859 | PubTator, text mining | PubMed |
| Molecular imaging of cellular immunotherapies in experimental and therapeutic settings. | Cancer Immunol Immunother | 2022 | 34657195 | PubTator, text mining | PubMed |
| The relationship between dose and serotonin transporter occupancy of antidepressants-a systematic review. | Mol Psychiatry | 2022 | 34548628 | PubTator, text mining | PubMed |
| The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder. | Curr Neuropharmacol | 2022 | 34544344 | PubTator, text mining | PubMed |
| Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance. | J Physiol | 2022 | 34505282 | PubTator, text mining | PubMed |
| Neuroimmune interactions and immunoengineering strategies in peripheral nerve repair. | Prog Neurobiol | 2022 | 34492307 | PubTator, text mining | PubMed |
| Organizing a Rational Approach to Treatments of Disorders of Consciousness Using the Anterior Forebrain Mesocircuit Model. | J Clin Neurophysiol | 2022 | 34474427 | PubTator, text mining | PubMed |
| Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA). | AJR Am J Roentgenol | 2022 | 34431366 | PubTator, text mining | PubMed |
| Multiple roles of cardiac macrophages in heart homeostasis and failure. | Heart Fail Rev | 2022 | 34387811 | PubTator, text mining | PubMed |
| The Lepidopteran KAAT1 and CAATCH1: Orthologs to Understand Structure-Function Relationships in Mammalian SLC6 Transporters. | Neurochem Res | 2022 | 34304372 | PubTator, text mining | PubMed |
| Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment. | Mol Psychiatry | 2022 | 34117366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6530/papers?page=33